Pathstone Holdings, LLC Incyte Corp Transaction History
Pathstone Holdings, LLC
- $21.2 Billion
- Q1 2024
A detailed history of Pathstone Holdings, LLC transactions in Incyte Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 6,825 shares of INCY stock, worth $449,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,825
Previous 5,688
19.99%
Holding current value
$449,562
Previous $357,000
8.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
619Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.38 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.53 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.5 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$1.02 Billion0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$652 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.7B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...